Carfilzomib and Famciclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carfilzomib (carfilzomib) and Famciclovir (famciclovir). Common drug interactions include oxygen saturation decreased among females and pneumonitis among males.

The phase IV clinical study analyzes what interactions people have when they take Carfilzomib and Famciclovir. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Carfilzomib?

Carfilzomib has active ingredients of carfilzomib. eHealthMe is studying from 13,486 Carfilzomib users. Check the latest studies of Carfilzomib.

What is Famciclovir?

Famciclovir has active ingredients of famciclovir. It is often used in herpes zoster. eHealthMe is studying from 3,389 Famciclovir users. Check the latest studies of Famciclovir.

On Jul, 04, 2026

26 people who take Carfilzomib and Famciclovir together, and have interactions are studied.

Carfilzomib and Famciclovir drug interactions.

What are the common drug interactions of Carfilzomib and Famciclovir, by gender? *:

female:

Oxygen saturation decreased
Plasma cell myeloma (cancer that begins in plasma cells)
Pyrexia (fever)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Cardiac disorder
Cardiac failure
Chills (felling of cold)
Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood)
Nausea (feeling of having an urge to vomit)

male:

Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Pulmonary toxicity (side effects on the lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)
Transitional cell carcinoma (cancer tumour inner most layer of urinary system)
Death
Lipoma (a growth of fatty tissue that slowly develops just under your skin)
Parainfluenzae virus infection

What are the common drug interactions of Carfilzomib and Famciclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Death
Lipoma (a growth of fatty tissue that slowly develops just under your skin)

50-59:

Plasma cell myeloma (cancer that begins in plasma cells)
Renal failure (kidney dysfunction)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)

60+:

Sepsis (a severe blood infection that can lead to organ failure and death)
Hepatic enzyme increased
Chills (felling of cold)
Hepatitis b
Hepatitis b core antibody positive
Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood)
Nausea (feeling of having an urge to vomit)
Palpitations (feelings or sensations that your heart is pounding or racing)
Parainfluenzae virus infection
Rash

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 24 people, 92.31%
High Blood Pressure: 7 people, 26.92%
Insomnia (sleeplessness): 4 people, 15.38%
Pain: 3 people, 11.54%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.54%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 7.69%
Cough: 2 people, 7.69%
Diarrhea: 2 people, 7.69%
Gastric Disorder (disease of stomach): 2 people, 7.69%
Headache (pain in head): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Carfilzomib and Famciclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously